Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour
Three-dimensional (3D) printing has been gaining attention as a new technological approach to obtain immediate release (IR) dosage forms. The versatility conferred by 3D printing techniques arises from the suitability of using different polymeric materials in the production of solids with different porosities, geometries, sizes, and infill patterns. The appropriate choice of polymer can facilitate in reaching IR specifications and afford other specific properties to 3D printed solid dosage forms. This review aims to provide an overview of the polymers that have been employed in the development of IR 3D printed dosage forms, mainly considering their in vitro drug release behaviour. The physicochemical and mechanical properties of the IR 3D printed dosage forms will also be discussed, together with the manufacturing process strategies. Up to now, methacrylic polymers, cellulosic polymers, vinyl derivatives, glycols and different polymeric blends have been explored to produce IR 3D printed dosage forms. Their effects on drug release profiles are critically discussed here, giving a complete overview to drive formulators towards a rational choice of polymeric material and thus contributing to future studies in 3D printing of pharmaceuticals.
Excipients used in 3D Printing mentioned in the study besides other: Eudragit E PO, Eudragit RL; Kollidon VA64, Parteck MXP; Affinisol HPMC, PVP K12, PVP K25
Nadine Lysyk Funk, Stephani Fantaus, Ruy Carlos Ruver Beck,
Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour, International Journal of Pharmaceutics, Volume 625, 2022, 122066, ISSN 0378-5173, https://doi.org/10.1016/j.ijpharm.2022.122066.